MPL and myeloproliferative disorder: Samples from patients with diagnoses capable of morphologically mimicking MPN (e.g. ITP treated with thrombopoietin receptor agonists, systemic inflammatory or autoimmune disorders and other malignancies) were deliberately excluded.